PCAR-119
/ PersonGen Biomedicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 30, 2019
Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
(clinicaltrials.gov)
- P1; N=9; Not yet recruiting; Sponsor: Allife Medical Science and Technology Co., Ltd.; Initiation date: Nov 2018 ➔ Mar 2019
Clinical • Trial initiation date
1 to 1
Of
1
Go to page
1